Early intervention studies have challenged the notion that lowering blood pressure is beneficial in women with mild hypertension. In contrast, results of more recent trials have clearly shown that treatment of hypertension is of benefit in women, particularly in elderly women. Aggressive treatment of hypertension is advisable in this subset of the population that is exposed to a greater risk of hypertension-related cardiovascular diseases because of the greater prevalence of hypertension and of its inadequate treatment. Hypertensive women are preferentially treated with diuretics but the rationale for this therapeutic selection is unclear. Calcium antagonists, beta-blockers and angiotensin-converting enzyme inhibitors exert an antihypertensive action similar to that of diuretics, but their use is limited by the adverse effects that are more frequent in women than in men. Angiotensin II receptor antagonists, being effective in lowering blood pressure and particularly well tolerated, may represent, in the future, the first-line drugs for treating hypertension in women.

Download full-text PDF

Source

Publication Analysis

Top Keywords

treating hypertension
8
hypertension women
8
lowering blood
8
blood pressure
8
treatment hypertension
8
women
7
hypertension
5
women open-ended
4
open-ended questions
4
questions therapeutic
4

Similar Publications

Background: Guidelines recognized dual combination in initial antihypertensive therapy. Studies found that low-dose quadruple combination were superior to monotherapy. However, whether low-dose quadruple therapy is better than dual combination is unknown.

View Article and Find Full Text PDF

The inflammatory response of lung tissue and abnormal proliferation of pulmonary artery smooth muscle cells are involved in the pathogenesis of high-altitude pulmonary hypertension (HAPH). Halofuginone (HF), an active ingredient derivative of Chang Shan (Dichroa febrifuga Lour. [Hydrangeaceae]), has antiproliferative, antihypertrophic, antifibrotic, and other effects, but its protective effects on HAPH remains unclear.

View Article and Find Full Text PDF

Sucrose-preferring gut microbes prevent host obesity by producing exopolysaccharides.

Nat Commun

January 2025

Laboratory of Molecular Neurobiology, Graduate School of Biostudies, Kyoto University, Sakyo-ku, Kyoto, Japan.

Commensal bacteria affect host health by producing various metabolites from dietary carbohydrates via bacterial glycometabolism; however, the underlying mechanism of action remains unclear. Here, we identified Streptococcus salivarius as a unique anti-obesity commensal bacterium. We found that S.

View Article and Find Full Text PDF

Approximately one-third of patients with breast cancer have comorbidities at the time of their diagnosis. Recommendations for managing metastatic breast cancer are usually based on the results of clinical trials, which often limit patients with comorbidities. However, comorbidities greatly influence the quality of life, patient survival rate and treatment choice, particularly in older patients.

View Article and Find Full Text PDF

Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Hemodialysis: An International, Multicentric Registry.

JACC Clin Electrophysiol

January 2025

Cardioangiologisches Centrum Bethanien, Agaplesion Markus-Krankenhaus, Frankfurt am Main, Germany.

Background: The net benefit of oral anticoagulation in patients with end-stage renal disease on hemodialysis (HD) is uncertain. In recent years, left atrial appendage closure (LAAC) has emerged as an alternative to oral anticoagulation; however, there is scant evidence of LAAC in patients on HD.

Objectives: This study aimed to assess the feasibility and safety of LAAC in patients on HD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!